Stock Code: 002332 Stock Abbreviation: Xianju Pharmaceutical Announcement No.: 2026-006
Zhejiang Xianju Pharmaceutical Co., Ltd. Resolution Announcement of the Second Meeting of the Ninth Board of Directors
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or major omissions.
On April 21, 2026, the Second Meeting of the Ninth Board of Directors of Zhejiang Xianju Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was held in the Company's conference room in person. The notice and meeting materials for this meeting were sent to all directors via email on April 9, 2026. There were 9 directors entitled to attend this meeting, and 9 directors attended in person. Senior management personnel of the Company attended the meeting. The meeting was convened in accordance with the "Company Law of the People's Republic of China" and the "Articles of Association" and other relevant regulations. The meeting was convened and presided over by Chairman Mr. Zhang Yusong. The attending directors passed the following resolutions by written ballot:
I. The "2025 Annual Work Report of the Board of Directors" was reviewed and approved. This proposal needs to be submitted to the 2025 Annual Shareholders' Meeting for review. The specific content of the "2025 Annual Work Report of the Board of Directors" can be found in the "Management Discussion and Analysis" section of the Company's "2025 Annual Report" disclosed on the Juchao Information Network (www.cninfo.com.cn) on April 23, 2026. The independent directors submitted the "2025 Annual Performance Report of Independent Directors" to the Board of Directors, and they will give a report at the 2025 Annual Shareholders' Meeting. The specific content can be found on the Juchao Information Network (www.cninfo.com.cn) on April 23, 2026. Voting results: 9 votes in favor, 0 votes against, 0 abstentions.